Target intelligence / Profile preview

Mitochondrial ribosomal protein L20 (MRPL20)

Target
MRPL20
Molecular classification
Other (mitochondrial ribosomal protein; structural constituent of large ribosomal subunit)
01

Overview

Mitochondrial ribosomal protein L20 (MRPL20) is a nuclear-encoded protein that constitutes a component of the large 39S subunit of the mammalian mitochondrial ribosome (mitoribosome). MRPL20 plays a structural role, supporting mitochondrial translation by participating in the assembly and function of the mitoribosome, which synthesizes mitochondrial-encoded proteins essential for oxidative phosphorylation and cellular energy metabolism. Unlike cytoplasmic ribosomal proteins, MRPL20 is specific to the mitochondrion and displays sequence variation across species. Defects in MRPL20 or its expression have been associated with mitochondrial dysfunction and, in rare cases, with diseases such as autosomal recessive early-onset Parkinson disease. There are currently no known drugs that specifically target MRPL20, nor is it considered a direct therapeutic target, but its role in fundamental mitochondrial protein synthesis is critical for normal cell function.

Other names
bL20mL20mtMRP-L20FLJ1002439S ribosomal protein L20, mitochondrialmitochondrial large ribosomal subunit protein bL20mLOC642393LOC6872532610008D01Rik4930425I20Rik
02

Biological functions

Mitochondrial protein synthesisTranslationRNA bindingrRNA binding
03

Disease associations

Parkinson disease (specifically Parkinson disease 7, autosomal recessive early-onset)Other (limited disease associations noted)

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L20 (MRPL20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L20 (MRPL20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call